F. Liu Central South University (CSU) Changsha China
Dr. Liu is an Assistant Professor of the Department of neurosurgery, Xiangya Hospital, centered on brain tumor therapeutics, brain organoid research, and drug screening. His doctoral training was in Neurosurgery at Central South University, and stem cell research in Houston Methodist Research Institute, Cornell University. A major goal of his research is basic-translation-clinical research by utilizing in vitro and in vivo cultured and primary models of the brain to study the molecular pharmacology and mechanisms of glioma and neuropsychiatric diseases pathogenesis. He published more than 11 original papers on identifying molecular markers in brain diseases and drug screening using brain organoid models.
J. Xu Shenzhen University Shenzhen China
Dr. Jianyong Xu obtained his Ph.D. degree (in 2016) in the field of Medicine from The University of Hong Kong, Hong Kong. Dr. Xu is currently working as Assistant Professor, in the School of Medicine, at Shenzhen University, Shenzhen, China. His research interests mainly lie in the subject areas/fields of stem cell biology, genome editing, gene therapy and their therapeutic applications. Dr. Xu, as an author/co-author, has published more than 20 manuscripts in various journals of international repute, and his documents have received over 2,290 citations.
M. Zhang Xi'an Medical University Xi'an China
Dr. Mingxin Zhang is presently serving as a Associate professor in Department of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, Xi’an, China. He completed M.D. in 2008 and then Ph.D. in 2011 from Xi’an Jiaotong University School of Medicine, Xi’an, China. His research interest includes Molecular mechanisms of carcinogenesis in gastroenterology and hepatology cancer Diagnosis and screening of colorectal cancer and Role of non-coding RNA in cancer. He has contributed his valuable publications in different scientific journals.
Liang Cheng College of Bioinformatics Science and Technology Harbin Medical University Harbin, Heilongjiang China
Dr. Cheng obtained a doctorate (Ph.D.) in Bioinformatics from Harbin
Institute of Technology, Harbin, Heilongjiang, China. Currently Dr. Cheng
is a Professor and PI of Biological Software Engineering in Harbin Medical
University. He has published more than 70 scientific publications since
2013. Dr. Cheng develops novel algorithms and tools for gene therapy of
Type 2 Diabetes Mellitus and complex diseases.